The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective, longitudinal digital activity monitoring before and after treatment of low-risk oropharyngeal squamous cell carcinoma: A feasibility study.
 
Gary Brandon Gunn
No Relationships to Disclose
 
Renata Ferrarotto
Consulting or Advisory Role - Ayala Pharmaceuticals; Cellestia Biotech; E.R. Squibb Sons, LLC; Sanofi/Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Merck Serono (Inst); Pfizer/EMD Serono (Inst)
 
Faye M. Johnson
Honoraria - Methodist Hospital
Research Funding - PIQUR; Takeda; Trovagene
 
Diana Bell
No Relationships to Disclose
 
Richard Cardoso
No Relationships to Disclose
 
Jason Michael Johnson
No Relationships to Disclose
 
M. Laura Rubin
No Relationships to Disclose
 
Ying Yuan
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - Boehringer Ingelheim; Midas Medical Technologies; Salzman Group
 
Steven J. Frank
Leadership - C4 Imaging; National Comprehensive Cancer Network
Stock and Other Ownership Interests - C4 Imaging
Honoraria - Boston Scientific; Hitachi Chemical; Varian Medical Systems
Consulting or Advisory Role - Breakthrough Chronic Care; Hitachi Chemical; Varian Medical Systems
Research Funding - ELEKTA; Hitachi Chemical; Lilly
Patents, Royalties, Other Intellectual Property - I have developed patents at the UT MD Anderson Cancer Center. These patents have been licensed to C4 Imaging.
Travel, Accommodations, Expenses - Boston Scientific; National Comprehensive Cancer Network
 
Clifton David Fuller
No Relationships to Disclose
 
David Ira Rosenthal
Stock and Other Ownership Interests - Concordia Pharmaceuticals
Consulting or Advisory Role - Merck Serono
Travel, Accommodations, Expenses - Merck Serono
 
Michael Elliot Kupferman
Stock and Other Ownership Interests - Abbvie; Intersect ENT
 
Ryan Goepfert
No Relationships to Disclose
 
Amy Clark Hessel
No Relationships to Disclose
 
Kate A. Hutcheson
No Relationships to Disclose
 
Neil D. Gross
Honoraria - Intuitive Surgical
Consulting or Advisory Role - PDS Biotechnology; Sanofi/Regeneron; Verb Surgical (Inst)
Research Funding - Genentech (Inst); MedImmune (Inst); Regeneron